Cargando…

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy

In cancer treatments, many natural and synthetic products have been examined; among them, protease inhibitors are promising candidates for anti-cancer agents. Since dysregulated proteolytic activities can contribute to tumor development and metastasis, antagonization of proteases with tailored inhib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudzińska, Magdalena, Daglioglu, Cenk, Savvateeva, Lyudmila V, Kaci, Fatma Necmiye, Antoine, Rodolphe, Zamyatnin Jr, Andrey A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797289/ https://www.ncbi.nlm.nih.gov/pubmed/33442233 http://dx.doi.org/10.2147/DDDT.S285852

Ejemplares similares

Structure determinants defining the specificity of papain-like cysteine proteases
por: Petushkova, Anastasiia I., et al.
Publicado: (2022)

The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance
por: Rudzińska, Magdalena, et al.
Publicado: (2019)

Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2021)

Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2020)

Overview of Celiac Disease in Russia: Regional Data and Estimated Prevalence
por: Savvateeva, Lyudmila V., et al.
Publicado: (2017)

Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
por: Baldin, Alexey V., et al.
Publicado: (2020)

Rational Design of Recombinant Papain-Like Cysteine Protease: Optimal Domain Structure and Expression Conditions for Wheat-Derived Enzyme Triticain-α
por: Gorokhovets, Neonila V., et al.
Publicado: (2017)

Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations
por: Petushkova, Anastasiia I., et al.
Publicado: (2020)

Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
por: Parodi, Alessandro, et al.
Publicado: (2019)

Smart Nanotheranostics Responsive to Pathological Stimuli
por: Parodi, Alessandro, et al.
Publicado: (2020)

Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2021)

Nanomedicine for increasing the oral bioavailability of cancer treatments
por: Parodi, Alessandro, et al.
Publicado: (2021)

Nanosized Drug Delivery Systems to Fight Tuberculosis
por: Bourguignon, Tom, et al.
Publicado: (2023)

Nanosized drug delivery strategies in osteosarcoma chemotherapy
por: Chen, Chenglong, et al.
Publicado: (2023)

Albumin Nanovectors in Cancer Therapy and Imaging
por: Parodi, Alessandro, et al.
Publicado: (2019)

Indispensable Role of Proteases in Plant Innate Immunity
por: Balakireva, Anastasia V., et al.
Publicado: (2018)

Cutting Out the Gaps Between Proteases and Programmed Cell Death
por: Balakireva, Anastasia V., et al.
Publicado: (2019)

Helicobacter pylori and gastric cancer: a lysosomal protease perspective
por: Soond, Surinder M., et al.
Publicado: (2021)

New Advances in the Understanding of Proteases as Diagnostic and Pharmaceutical Targets in Homeostatic and Pathologic Conditions
por: Zamyatnin, Andrey A., et al.
Publicado: (2022)

IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
por: Jalilian, Amir R., et al.
Publicado: (2022)

Current status of breast cancer prevention in China
por: Wang, Fei, et al.
Publicado: (2015)

Current status of core needle biopsy of the thyroid
por: Baek, Jung Hwan
Publicado: (2017)

Redox-Mediated Post-Translational Modifications of Proteolytic Enzymes and Their Role in Protease Functioning
por: Petushkova, Anastasiia I., et al.
Publicado: (2020)

Interventional Radiology in China: Current Status and Future Prospects
por: Zhao, He, et al.
Publicado: (2017)

Pharmacological management of portal hypertension: current status and future
por: Gao, Zhu-Qing, et al.
Publicado: (2020)

Family Herpesviridae and neuroinfections: current status and research in progress
por: Carneiro, Vanessa Cristine de Souza, et al.
Publicado: (2022)

Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates
por: Kobayashi, Hisataka, et al.
Publicado: (2014)

Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota
por: Karavolos, Michail, et al.
Publicado: (2016)

Current trends in domestic status and insurance policy for use of plasma
por: Lim, Young Ae
Publicado: (2010)

Intracranial artery stenosis: Current status of evaluation and treatment in China
por: Cai, Bin, et al.
Publicado: (2017)

Hematopoietic stem cell mobilization: current status and future perspective
por: Kim, Jin Seok
Publicado: (2017)

Neuroscience education and research in Cameroon: Current status and future direction
por: Mbiydzenyuy, Ngala Elvis, et al.
Publicado: (2021)

Current status and perspectives of conversion therapy for advanced gastric cancer
por: Yang, Heli, et al.
Publicado: (2022)

Precision medicine for acute pancreatitis: current status and future opportunities
por: Mukherjee, Rajarshi, et al.
Publicado: (2019)

Cellular Aging Characteristics and Their Association with Age-Related Disorders
por: Rudzińska, Magdalena, et al.
Publicado: (2020)

Current status of advanced gastrointestinal endoscopy training fellowships in the United States
por: Heller, Stephen J, et al.
Publicado: (2011)

Antimicrobial resistance in the WHO African region: current status and roadmap for action
por: Essack, S.Y., et al.
Publicado: (2017)

Spreading of Human Babesiosis in China: Current Epidemiological Status and Future Challenges
por: Chen, Muxin, et al.
Publicado: (2020)

Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
por: Lv, Li, et al.
Publicado: (2021)

Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
por: Boyuklieva, Radka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gdb88m8p6i01mm1fq89p029spq